Interferon-gamma: Clinical Trials

32 trials of Interferon-gamma, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

23 completed, 4 unknown, 3 terminated, 1 recruiting. 32 Phase 2, 7 Phase 1, 3 Phase 3.

By phase and status

PhaseTrialsStatus
Phase 232Completed 23, Unknown 4, Terminated 3, Recruiting 1, Withdrawn 1
Phase 17Completed 4, Terminated 2, Withdrawn 1
Phase 33Completed 2, Recruiting 1

Follow Interferon-gamma: new trials by email Literature Review of Interferon-gamma trials Research Report on Interferon-gamma

Trials (filtered) newest first · largest first

All 32 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Effect of Interferon Gamma as a Treatment for Post-aggressive Immunosuppression in Intensive Care Units, a Randomized Bayesian Double-blind Controlled Trial Versus Placebo
Interferon Gamma 1-b, Placebo - Post-aggressive Immunosuppression, Adult Patients Admitted to Intensive Care With Initial Severity (SOFA of the First 24 Hours Post-admission ≥ 6
Phase 2 / Phase 3RecruitingAssistance Publique - Hôpitaux de Paris1702026-02-242026-11-12
Gene-Modified Immune Cells (FH-MCVA2TCR) in Treating Patients With Metastatic or Unresectable Merkel Cell Cancer
Autologous MCPyV-specific HLA-A02-restricted TCR-transduced CD4+ and CD8+ T-cells FH-MCVA2TCR, Avelumab, Pembrolizumab - Other Skin
Phase 1 / Phase 2TerminatedFred Hutchinson Cancer Center72019-07-032025-03-06
Testing the Combination of Two Experimental Drugs MK-3475 (Pembrolizumab) and Interferon-gamma for the Treatment of Mycosis Fungoides and Sézary Syndrome and Advanced Synovial Sarcoma
Interferon Gamma-1b, Laboratory Biomarker Analysis, Pembrolizumab - Metastatic Myxoid Liposarcoma, Metastatic Round Cell Liposarcoma
Phase 2CompletedNational Cancer Institute (NCI)282017-12-142023-10-25
Phase I-II Study of Interferon-gamma in Patients With HER-2 Positive Breast Cancer
Interferon-gamma (IFN-γ), Paclitaxel, Trastuzumab - Breast Cancer, Breast Cancer, Male
Phase 1 / Phase 2CompletedH. Lee Moffitt Cancer Center and Research Institute512017-06-232023-04-19
Open Trail of γIFN for Friedreich Ataxia
gamma interferon - Friedreich Ataxia
Phase 2CompletedIRCCS Eugenio Medea122016-06-262020-02-26
A Phase IIa Trial to Test Safety and Efficacy Interferon Gamma Treatment in Elevating Frataxin Levels in FRDA Patients
gamma interferon - Friedreich Ataxia
Phase 2CompletedAzienda Policlinico Umberto I102013-05-012017-04-21
A Phase II Trial on Treatment of Steroid-refractory Bronchiolitis Obliterans With Interferon Gamma 1b After Allogeneic SCT
Interferon gamma 1b - Steroid-refractory Bronchiolitis Obliterans
Phase 2UnknownUniversity Hospital Regensburg102012-07-012012-07-12
A Phase II Study to Determine the Safety and Efficacy of Interferon-gamma in Patients With Chronic Hepatitis B
IFN-γ 1b (Actimmune), Adefovir dipivoxil, IFN-γ 1b and Adefovir dipivoxil combination - Hepatitis B
Phase 2UnknownHuntington Medical Research Institutes302008-09-012010-10-21
Study of Gamma Interfereon in Metastatic Colorectal Carcinoma
5-Fluorouracil, Leucovorin (LV), Gamma-Interferon-1b (IFN-γ) - Colorectal Cancer
Phase 2CompletedAccelerated Community Oncology Research Network482006-02-012012-03-01
Study of Interferon-Gamma in the Complex Treatment of Patients Infected With HIV and Tuberculosis
Interferon-Gamma - HIV Coinfection, Aids/Hiv Problem
Phase 1 / Phase 2CompletedSPP Pharmaclon Ltd.782006-01-192024-01-25
Interferon Gamma With Peg-Interferon Alpha 2a and Ribavirin in Non Responders Patients With Chronic Hepatitis C
Peg-interferon alpha 2a (drug), Ribavirin (drug), Interferon gamma (drug) - Hepatitis C, Chronic
Phase 2CompletedFrench National Agency for Research on AIDS and Viral Hepatitis652004-06-012007-08-30
Immunotherapy Using Cyclosporine, Interferon Gamma, and Interleukin-2 After High-Dose Myeloablative Chemotherapy With Autologous Stem Cell Transplantation in Treating Patients With Refractory or Relapsed Hodgkin's Lymphoma
aldesleukin, filgrastim, recombinant interferon gamma - Lymphoma
Phase 2 / Phase 3CompletedChildren's Oncology Group242003-11-012013-10-17
Voriconazole With or Without Interferon Gamma in Treating Patients With Aspergillosis or Other Fungal Infections
recombinant interferon gamma, voriconazole - Infection, Unspecified Adult Solid Tumor, Protocol Specific
Phase 2CompletedNational Cancer Institute (NCI)2003-08-012013-06-19
New Immunomodulatory Therapy Strategies in Chronic Reactive Arthritis
interferon-gamma, infliximab, dmard - Reactive Arthritis
Phase 2UnknownCharite University, Berlin, Germany402003-01-012006-09-08
Chemoimmunotherapy Study for Patients With Epithelial Ovarian Cancer
Carboplatin, GM-CSF (Sargramostim), Interferon Gamma - Ovarian Cancer, Fallopian Tube Cancer
Phase 2CompletedM.D. Anderson Cancer Center592003-01-012012-08-07
ITV Extension Study
recombinant fowlpoxvirus (rFPV) expressing HIV gag-pol antigens, HIV gag-pol antigens and interferon-gamma (IFN-y) - HIV
Phase 1 / Phase 2CompletedKirby Institute352002-09-012007-02-27
An Open-Label Study of the Safety and Efficacy of Subcutaneous Recombinant Interferon-Gamma 1b (IFN-Gamma 1b) in Patients With Idiopathic Pulmonary Fibrosis (IPF)
interferon-gamma 1b - Lung Disease, Pulmonary Fibrosis
Phase 2CompletedInterMune2102002-09-012007-11-06
Gamma Interferon Therapy for Chronic Hepatitis C
Gamma Interferon 1b - Chronic Hepatitis C
Phase 2CompletedNational Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)202001-12-012008-03-04
A Study of the Safety and Clinical Effects of Interferon Gamma-1b in Patients With Idiopathic Pulmonary Fibrosis (IPF)
Interferon-gamma 1b - Idiopathic Pulmonary Fibrosis
Phase 2CompletedInterMune322001-11-012007-11-06
Interferon-gamma or Aldesleukin and Vaccine Therapy in Treating Patients With Multiple Myeloma
aldesleukin, idiotype-pulsed autologous dendritic cell vaccine APC8020, recombinant interferon gamma - Multiple Myeloma and Plasma Cell Neoplasm
Phase 2CompletedMayo Clinic152001-08-012011-05-16

Showing 20 of 32. Sign in to see all of them.

Conditions studied

Breast Neoplasms (2)  ·  Colonic Neoplasms (2)  ·  Colorectal Neoplasms (2)  ·  Friedreich Ataxia (2)  ·  Hepatitis C (2)  ·  Hepatitis C, Chronic (2)  ·  Idiopathic Pulmonary Fibrosis (2)  ·  Mesothelioma, Malignant (2)  ·  Mycobacterium Infections (2)  ·  Pneumonia (2)  ·  Tuberculosis, Pulmonary (2)  ·  Acquired Immunodeficiency Syndrome (1)  ·  Arthritis, Reactive (1)  ·  Breast Neoplasms, Male (1)  ·  Bronchiolitis Obliterans (1)

Sponsors

National Institute of Allergy and Infectious Diseases (NIAID) (4)  ·  National Cancer Institute (NCI) (3)  ·  InterMune (2)  ·  Accelerated Community Oncology Research Network (1)  ·  Aga Khan University (1)  ·  Assistance Publique - Hôpitaux de Paris (1)  ·  Azienda Policlinico Umberto I (1)  ·  Charite University, Berlin, Germany (1)  ·  Children's Oncology Group (1)  ·  Columbia University (1)  ·  Fred Hutchinson Cancer Center (1)  ·  French National Agency for Research on AIDS and Viral Hepatitis (1)  ·  H. Lee Moffitt Cancer Center and Research Institute (1)  ·  Herbert Irving Comprehensive Cancer Center (1)  ·  Hoag Memorial Hospital Presbyterian (1)

Countries

United States (21)  ·  Australia (2)  ·  France (2)  ·  Germany (2)  ·  Canada (1)  ·  Italy (1)  ·  Pakistan (1)  ·  Russia (1)

Top investigators

Allen R. Chen, MD, PhD, MHS (1)  ·  Andrea Martinuzzi, MD (1)  ·  Benjamin Chousterman, Professor (1)  ·  Carlo Casali, MD (1)  ·  Charles L. Wiseman, MD, FACP (1)  ·  David A Cooper, AO DSc MD FRACP FRCPA FRCP (1)  ·  Ernst Holler, Professor MD (1)  ·  Gwen L. Nichols, MD (1)  ·  Javier Szwarcberg, MD (1)  ·  Jeffrey S. Weber, MD, PhD (1)  ·  Joshua Veatch (1)  ·  Lee Schwartzberg, MD (1)  ·  Martha Q. Lacy, MD (1)

Results publications

PMID 10850352, PMID 12843799, PMID 15940636, PMID 15994231, PMID 16912304, PMID 17030856, PMID 19264351, PMID 2106474, PMID 22755276, PMID 23190183, PMID 2452123, PMID 3129521, PMID 32269142, PMID 35880940, PMID 42715345, PMID 8368765, PMID 8399072

NIH funding

2004 (1), 2023 (1), P01CA225517 (1), P30CA015083 (1), P30CA015704 (1), U01CA154967 (1)